Westfield Capital Management’s Fate Therapeutics FATE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-1,386,058	Closed	-$14M	–	235
2022 Q4	$14M	Sell	1,386,058 -5,159	-0.4%	-$96.9K	0.11%	168
2022 Q3	$31.2M	Sell	1,391,217 -403,031	-22%	-$11.6M	0.25%	142
2022 Q2	$44.5M	Buy	1,794,248 +573,927	+47%	+$15.8M	0.35%	101
2022 Q1	$47.3M	Buy	1,220,321 +740,673	+154%	+$28.7M	0.3%	117
2021 Q4	$28.1M	Buy	479,648 +188,547	+65%	+$10.7M	0.17%	154
2021 Q3	$17.3M	Sell	291,101 -10,550	-3%	-$828K	0.1%	174
2021 Q2	$26.2M	Buy	301,651 +44,934	+18%	+$3.62M	0.16%	167
2021 Q1	$21.2M	Buy	256,717 +97,078	+61%	+$9.3M	0.13%	172
2020 Q4	$14.5M	Sell	159,639 -250,690	-61%	-$15.6M	0.09%	183
2020 Q3	$16.4M	Sell	410,329 -27,994	-6%	-$977K	0.11%	177
2020 Q2	$15M	Buy	438,323 +26,227	+6%	+$782K	0.1%	184
2020 Q1	$9.15M	Sell	412,096 -292,747	-42%	-$7.4M	0.08%	178
2019 Q4	$13.8M	Sell	704,843 -200,776	-22%	-$3.19M	0.1%	178
2019 Q3	$14.1M	Buy	905,619 +46,870	+5%	+$898K	0.11%	174
2019 Q2	$17.4M	Sell	858,749 -34,676	-4%	-$625K	0.13%	182
2019 Q1	$15.7M	Sell	893,425 -210,880	-19%	-$3.33M	0.12%	187
2018 Q4	$14.2M	Buy	1,104,305 +272,235	+33%	+$3.8M	0.12%	177
2018 Q3	$13.6M	Buy	832,070 +26,610	+3%	+$315K	0.1%	191
2018 Q2	$9.13M	Buy	+805,460	New	+$8.87M	0.07%	205

Other funds holding FATE